News

Living with Bleeding Disorders in the Time of COVID

COVID-19, Living with a Bleeding Disorder

by: Sari Harrar Pandemic stories of strength, perseverance and resiliency from three members of the bleeding disorders community. The COVID-19 pandemic has…

Read More

TARPA-H Overview

Industry News & Research

President Biden has called for the creation of a new $6.5 billion research institute, the Advanced Research Projects Agency for Health (ARPA-H),…

Read More

Four Decades of HIV

Health and Well Being, Industry News & Research, Living with a Bleeding Disorder

This past June marked a significant milestone for the bleeding disorders community. Forty years ago, on June 5, 1981, the CDC first…

Read More

COVID-19: Health and Wellness Update from NHF’s Dr. Leonard Valentino

COVID-19, Industry News & Research

The cautious optimism of May and June with regards to emerging from the pandemic has shifted as we are witnessing a resurgence…

Read More

Spark Provides Trial Updates for Investigational Gene Therapy SPK-8011

Industry News & Research

SPK-8011 is Spark Therapeutics’ investigational gene therapy candidate for hemophilia A. Spark Therapeutics recently announced updates from an ongoing phase 1/2 clinical…

Read More

New Descriptive Study Looks at Bleeding Disorder Camps

Industry News & Research

The study included a number of notable findings relevant to the participation of healthcare providers in bleeding disorder camps (BDCs), adherence to…

Read More

NHF Responds to New CMS Guidance

Industry News & Research

New guidance from the U.S. Department of Health and Human Services encourages states to educate eligible immigrants about Medicaid coverage. In a…

Read More

BioMarin Hemophilia A Clinical Development Program: An Update for the Hemophilia Community

Industry News & Research

BioMarin is pleased to update the community regarding our ongoing gene therapy clinical trial program in hemophilia A. BioMarin’s investigational gene therapy…

Read More

Review Your Health Coverage: Recent Federal Law Lowers Costs, Opens Up New Options

Advocacy & Legislation, Industry News & Research

The American Rescue Plan (ARP), signed into law on March 11, 2021, provides new opportunities to get health insurance coverage, and/or to…

Read More

New Data for Genentech’s Hemlibra (emicizumab-kxwh) Reinforce Safety Profile in People With Hemophilia A

Industry News & Research

Final analysis from the Phase IIIb STASEY study, including data from 193 people with hemophilia A, further support the benefit/risk profile of…

Read More

FDA Places Clinical Hold on Sigilon’s Investigational Hemophilia Therapy

Industry News & Research

Sigilon’s cell-based therapy is designed to carry significant amounts of synthetic DNA material to elicit the production of factor VIII in individuals…

Read More

Learn More About Shared Decision Making in Hemophilia

Health and Well Being

Shared decision making (SDM) in hemophilia embraces a “patient-as-partner” style for a truly reciprocal relationship. Learn more about both the process and…

Read More

NHF Responds to SCOTUS: New Affordable Care Act Ruling Benefits Chronic Disease Patients

Advocacy & Legislation

Dr. Valentino: “Today’s decision protects members of the inheritable blood disorder community, as well as others” Today, the United States Supreme Court…

Read More

New Article Offers Scientific Overview of AAV Vectors and Hemophilia Gene Therapy

Industry News & Research

Read about some of the primary considerations relevant to investigational hemophilia gene therapies that employ adeno-associated viral (AAV) vectors. Source: National Hemophilia…

Read More

Wisconsin State Journal: Don’t Let Insurers Undermine Copay Help for Wisconsin Patients

Advocacy & Legislation, Industry News & Research

by: Sen. André Jacque and Rep. Paul Tittl | April 17, 2021 The health and economic impacts of the ongoing pandemic have…

Read More

The Unite for Bleeding Disorders Walk is September 25! Learn More and Register Today!

GLHF News

The 2021 Unite for Bleeding Disorders Walk is just three months away! We are so excited to see all of you this…

Read More

Madison’s Best Bloody 2021 is Cancelled. So, Be Ready for Tastings in 2022!

GLHF News

We are sad to announce that due to the current situation in Madison, we are cancelling this year’s Madison’s Best Bloody.  Restaurants…

Read More

Camp Klotty Pine Registration Opens Soon!

GLHF News

Join us, August 9 – 13, 2021, as we head back to Camp Klotty Pine for a very special hybrid version of…

Read More

NHF’s Bleeding Disorders Conference, August 25 – 28, 2021!

Industry News & Research

NHF’s Annual Bleeding Disorders Conference (BDC) is their signature event and highlights their commitment to education. Leading community members and experts on…

Read More

A Message from NHF President and CEO Leonard A. Valentino, M.D. Regarding the Fight Against Racism

Health and Well Being, Industry News & Research

The verdict is an important and significant step forward in the fight against racism, and the violence that it brings to our…

Read More

WFH: Specific Risks of COVID-19 to the Bleeding Disorders Community

COVID-19, Industry News & Research

The COVID-19 Task Force of the World Federation of Hemophilia (WFH) has released a statement on risks of acquiring COVID-19 disease and…

Read More

BioMarin Presents Positive Safety and Efficacy Data for their Hemophilia A Gene Therapy

Industry News & Research

These data were presented by BioMarin at the American Society of Gene & Cell Therapy Virtual Meeting, which was held May 11-14,…

Read More

Gene Therapy Trial Data Suggests Efficacy in the Presence of Antibodies

Industry News & Research

The recent American Society of Gene & Cell Therapy (ASGCT) Virtual Meeting featured updates from the phase III HOPE-B clinical trial of…

Read More

NHF Marks the 40th Anniversary of the HIV Epidemic

Industry News & Research, Living with a Bleeding Disorder

June 3, 2021 – Statement from Nathan Schaefer, Vice President of Public Policy, National Hemophilia Foundation This June marks a painful anniversary…

Read More